Indirubin-3'-monoxime is a potent inhibitor of GSK-3β (IC50=22 nM)1. Indirubin-3'-monoxime also inhibits CDK1 (p34cdc2; IC50=180 nM) and CDK5 (IC50=100 nM)1. Indirubin-3'-monoxime reversibly arrests asynchronous HBL-100 cells at G22. This compound induces apoptosis in the mammary carcinoma cell line MCF-7 (10 µM). Indirubin-3'-monoxime is an inhibitor of Cdk2, cyclin A, cyclin B, cyclin E and p35.
1. Leclerc, S., et al. 2001. J. Biol. Chem. 276: 251-260. PMID: 11013232
Soluble in DMSO (6 mg/ml), ethanol (4 mg/ml), DMF (~10 mg/ml), 1:5 DMSO:PBS (pH 7.2) (0.15 mg/ml), and methanol. Insoluble in water.
bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of
Lee JJ; et alLee JJ; et al. (PubMed ID: 25451564) determined that Indirubin-3'-monoxime inhibited collagen-induced platelet aggregation by suppressing phospholipase C 2 (PLC 2) phosphorylation, in rat carotid artery injury model. -SCBT Publication Review
Creating an account with us makes your shopping experience much easier and faster. You can save favorites, save cart, check order status and speed through checkout with saved addresses, payment methods and more.